For the Inventor, By the Inventor

Enter assignee name

Lausanne, Switzerland

Gene Signal International Sa

USPTO Granted Patents = 20

CIPO Patents = 1

EPO Patents = 10

Forward Citations = 24

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Sylvie Colin (14 out of 15 patents)

Salman Al-Mahmood (13 out of 16 patents)

Salman Al Mahmood (5 out of 5 patents)

4. Antoine Ferry (3 out of 3 patents)

5. Eric Viaud (3 out of 3 patents)

6. Carla Missiaen (2 out of 2 patents)

7. Jo Vercammen (2 out of 7 patents)

8. Christophe Schneider (2 out of 3 patents)

9. Éric Viaud (1 out of 1 patent)

10. Jean-Pascal Conduzorgues (1 out of 3 patents)

11. Eric Thorin (1 out of 2 patents)

12. Maud Bongaerts (1 out of 1 patent)

13. Cèline Steverlynck (1 out of 1 patent)

14. Amel Hadri (1 out of 1 patent)

15. Éric Thorin (0 patent)

20 patents: Sort by Forward Citations

1. 11357790 - Sterile formulation comprising a stable phosphorothioate oligonucleotide (2022-06-14),

2. 10052343 - Sterile formulation comprising a stable phosphorothioate oligonucleotide (2018-08-21),

3. 9682144 - Composition comprising inhibitors of IRS-1 and of VEGF (2017-06-20),

4. 9539306 - Anti-tumor drug, medicament, composition, and use thereof (2017-01-10),

5. 9359604 - Inhibitor of IRS-1 for treating skin disorders (2016-06-07),

6. 9206236 - Peptides for treating cancer (2015-12-08),

7. 8828959 - Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells (2014-09-09),

8. 8742067 - Anti-tumor drug, medicament, composition, and use thereof (2014-06-03),

9. 8580947 - Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization (2013-11-12),

10. 8470997 - Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization (2013-06-25),

11. 8383591 - Peptides for treating cancer (2013-02-26),

12. 8372810 - Anti-tumor drug, medicament, composition, and use thereof (2013-02-12),

13. 8288334 - Peptides for wound healing (2012-10-16),

14. 8188044 - Anti-tumor drug, medicament, composition, and use thereof (2012-05-29),

15. 8133877 - Composition comprising an antisense sequence implicated in the regulation of angiogenesis (2012-03-13),

Gene Signal International SA is a biotechnology company specialized in developing innovative therapies for cancer and dermatological disorders. They focus on researching and exploiting the cellular communication circuitry, aiming to develop targeted treatments that modulate biological signals. With their cutting-edge technology and expertise, they strive to provide precise and effective therapies to improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

20 Patents

#17 in Lausanne

#594 in Switzerland

#30,364 in the World

Lausanne, Switzerland

Gene Signal International Sa

Forward Citations = 24

14 inventors:

Sylvie Colin (14 out of 15 patents)

Salman Al-Mahmood (13 out of 16 patents)

Salman Al Mahmood (5 out of 5 patents)

4. Antoine Ferry (3 out of 3 patents)

5. Eric Viaud (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…